✦ LIBER ✦

970 ALLOGENEIC GENETICALLY-MODIFIED TUMOR CELL VACCINE (RCC-26/CD80/IL-2) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - A PHASE I TRIAL

✍ Scribed by A. Buchner; H. Pohla; A. Baur; J. Kopp; A. Pezzutto; T. Blankenstein; D. Schendel; C. Stief; A. Hofstetter; R. Oberneder

Book ID: 119618286
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 316 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60965-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IMMUNE MONITORING OF AN ALLOGENIC GENETI

IMMUNE MONITORING OF AN ALLOGENIC GENETICALLY- MODIFIED TUMOR CELL VACCINE (RCC-26/CD80/IL-2) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Buchner, Alexander; Pohla, Heike; Frankenberger, Bernhard; Baur, Andrea; Stief, 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 124 KB

Allogeneic gene-modified tumor cells (RC

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

✍ Westermann, J; Flörcken, A; Willimsky, G; van Lessen, A; Kopp, J; Takvorian, A; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 715 KB

Phase I Trial of a B7-1 (CD80) Gene Modi

Phase I Trial of a B7-1 (CD80) Gene Modified Autologous Tumor Cell Vaccine in Combination With Systemic Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

✍ ANTONIA, SCOTT J.; SEIGNE, JOHN; DIAZ, JOSE; MURO-CACHO, CARLOS; EXTERMANN, MART 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 635 KB

Allogeneic Dendritic Cells Fused with Tu

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

✍ Marten, Angela; Renoth, Sabine; Heinicke, Thomas; Albers, Peter; Pauli, Andreas; 📂 Article 📅 2003 🏛 Mary Ann Liebert 🌐 English ⚖ 506 KB

Quality of life in patients with metasta

Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine

✍ Lorenzo Cohen; Carl de Moor; Patricia A Parker; Robert J Amato 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

271 Phase II Study of Thalidomide, inter

271 Phase II Study of Thalidomide, interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients with metastatic renal cell carcinoma (RCC)

✍ R. Amato; J. Brown; A. Rawat 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB